Jay S. Stout, Chief Technology Officer at Immunovant, Inc. ($IMVT), made nine open market sales of company shares over the past year, totaling about $328 thousand. His most recent sale occurred on January 21, 2026. These transactions rank 7,378th out of nearly 12,000 individual insiders, well below the average sale value of $8.6 million across 6.4 transactions per seller. Stout made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 1977 | $26.03 | 197,634.0000 | 175,276,526 | 0.99% | 0.00% |
| Jan. 7, 2026 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 55 | $26.92 | 199,611.0000 | 175,276,526 | 0.03% | 0.00% |
| Jan. 7, 2026 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 1148 | $26.51 | 199,666.0000 | 175,276,526 | 0.57% | 0.00% |
| Oct. 22, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 2520 | $19.03 | 200,814.0000 | 170,923,191 | 1.24% | 0.00% |
| Oct. 8, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 1585 | $16.30 | 203,334.0000 | 170,923,191 | 0.77% | 0.00% |
| July 23, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 2805 | $18.15 | 204,919.0000 | 170,923,191 | 1.35% | 0.00% |
| July 9, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 1519 | $17.24 | 207,724.0000 | 170,923,191 | 0.73% | 0.00% |
| April 23, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 1925 | $14.79 | 209,243.0000 | 0 | 0.91% | 0.00% |
| April 9, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 5004 | $12.99 | 211,168.0000 | 0 | 2.31% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | A | Stock Option (right to buy) | 107297 | $0.00 | 107,297.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | A | Common Stock | 76181 | $0.00 | 216,172.0000 | 0 | 54.42% | 0.00% |
| Jan. 22, 2025 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 2195 | $23.59 | 139,991.0000 | 0 | 1.54% | 0.00% |
| Oct. 23, 2024 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 2740 | $29.53 | 142,186.0000 | 0 | 1.89% | 0.00% |
| July 24, 2024 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 2813 | $27.76 | 144,926.0000 | 0 | 1.90% | 0.00% |
| April 24, 2024 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | S | Common Stock | 7239 | $28.90 | 147,739.0000 | 0 | 4.67% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Stout Jay S | Chief Technology Officer | A | Common Stock | 54978 | $0.00 | 154,978.0000 | 0 | 54.98% | 0.00% |